New Trial Upends Depression Playbook

A person sitting on the floor with their arms wrapped around their knees, conveying a sense of distress

Most depression treatments try to kill the pain — but a new approach asks a different question: what if you could teach the brain to feel good again?

Quick Take

Positive Affect Treatment (PAT) targets the brain’s reward system instead of just reducing negative emotions like sadness and fear.
A clinical trial published in JAMA Network Open found PAT outperformed standard negative-affect therapy on depression, anxiety, stress, and suicidal thoughts.
PAT showed a moderate-to-strong effect size, but the evidence comes from small trials and needs broader testing before it can replace existing treatments.
The biggest hurdle may be a surprising one: some patients are actually afraid of feeling positive emotions.

Depression Treatment Has Been Stuck in the Same Lane for Decades

Most talk therapy for depression works by targeting what feels bad. Therapists help patients challenge dark thoughts, reduce anxiety, and manage stress. That approach has helped millions of people. But for a large group of patients, cutting the negative is not enough. They still can’t feel joy, motivation, or pleasure — even when the sadness fades. That condition is called anhedonia, and it’s one of the hardest parts of depression to treat.

Anhedonia is not just feeling sad. It’s a broken reward system. The brain stops responding to things that used to bring pleasure — food, music, connection, achievement. Standard therapies were never built to fix that. They were built to reduce suffering, not restore the ability to feel good. That gap is exactly where Positive Affect Treatment (PAT) steps in.

What PAT Actually Does Inside the Brain

PAT is a structured therapy program designed to activate the brain’s reward circuits. It trains patients to notice, seek out, and savor positive experiences. Modules focus on things like anticipating rewards, being present during good moments, and building a sense of meaning. The goal is not to force fake happiness. It’s to rebuild the brain’s ability to process and hold onto genuine positive feelings. Researchers believe this directly targets the reward sensitivity that anhedonia destroys.^[4]

The science behind this is straightforward. The brain’s reward system runs on dopamine pathways. Depression, especially with anhedonia, dulls those pathways. PAT essentially works like physical therapy for a damaged muscle — repeated, guided activation to restore function. That mechanistic logic is one reason researchers took the approach seriously enough to run a full randomized clinical trial.^[7]

What the Clinical Trial Actually Found

A randomized clinical trial published in JAMA Network Open tested PAT directly against a therapy focused on reducing negative affect. PAT won on nearly every measure. Patients in the PAT group showed greater improvements in positive mood, depression severity, anxiety, stress, and suicidal thoughts at the six-month follow-up.^[8] The effect size was moderate to strong, which is meaningful in mental health research, where even small gains matter for patients who have tried everything else.^[5]

The trial also found that PAT improved reward sensitivity — the brain’s ability to anticipate and respond to good things — more than the comparison therapy did.^[4] That matters because it suggests PAT is not just making people feel better temporarily. It may be changing how the brain works. That’s a bigger claim than most therapies can make, and it deserves serious attention from clinicians.

The Honest Limits of the Current Evidence

The trial results are promising, but the honest read of the evidence requires some caution. The studies so far are relatively small. The comparator was another therapy, not standard medication or widely used treatments like cognitive behavioral therapy. Larger, multisite trials are needed before PAT can be called a proven superior option for most depression patients.^[3] Science moves in steps, and PAT is still early in that process.

There is also a fascinating wrinkle that researchers have flagged. Some patients actually fear positive emotions.^[6] They worry that feeling good means something bad is coming, or that happiness is dangerous or undeserved. For those patients, PAT faces a unique obstacle — the treatment itself triggers resistance. Identifying and addressing that fear is now part of the research conversation, and it adds a layer of complexity that simple drug trials don’t face.

Why This Approach Deserves More Attention Right Now

Depression affects roughly one in five adults at some point in their lives. Existing treatments fail a significant share of patients. Medications help many people but leave others stuck. Talk therapy reduces negative thinking but often doesn’t restore the ability to feel genuine pleasure. PAT addresses a real gap in the treatment toolkit, and its early results are strong enough to justify the next round of larger trials.^[1] The brain’s reward system is not a luxury feature — it’s central to motivation, relationships, and quality of life.

The idea that teaching people to feel good could be as powerful as teaching them to stop feeling bad is not just hopeful. It’s backed by a growing body of evidence that points in a consistent direction. PAT won’t replace every other treatment. But for the millions of patients who have lost the ability to feel pleasure, it may be the most targeted tool researchers have built yet.